Annual CFO
-$11.37 M
-$3.96 M-53.50%
December 31, 2023
Summary
- As of March 8, 2025, IMMX annual cash flow from operations is -$11.37 million, with the most recent change of -$3.96 million (-53.50%) on December 31, 2023.
- During the last 3 years, IMMX annual CFO has fallen by -$10.97 million (-2709.83%).
- IMMX annual CFO is now -2709.83% below its all-time high of -$404.70 thousand, reached on December 31, 2020.
Performance
IMMX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.04 M
+$1.22 M+23.21%
September 30, 2024
Summary
- As of March 8, 2025, IMMX quarterly cash flow from operations is -$4.04 million, with the most recent change of +$1.22 million (+23.21%) on September 30, 2024.
- Over the past year, IMMX quarterly CFO has dropped by -$949.40 thousand (-30.76%).
- IMMX quarterly CFO is now -7845.08% below its all-time high of -$50.80 thousand, reached on September 30, 2021.
Performance
IMMX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$15.80 M
-$949.40 K-6.39%
September 30, 2024
Summary
- As of March 8, 2025, IMMX TTM cash flow from operations is -$15.80 million, with the most recent change of -$949.40 thousand (-6.39%) on September 30, 2024.
- Over the past year, IMMX TTM CFO has dropped by -$3.20 million (-25.39%).
- IMMX TTM CFO is now -5829.54% below its all-time high of -$266.40 thousand, reached on March 31, 2021.
Performance
IMMX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IMMX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.5% | -30.8% | -25.4% |
| 3 y3 years | -2709.8% | -30.8% | -25.4% |
| 5 y5 years | -1339.4% | -30.8% | -25.4% |
IMMX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -615.5% | at low | -637.7% | +23.2% | -893.9% | at low |
| 5 y | 5-year | -2709.8% | at low | -7845.1% | +23.2% | -5829.5% | at low |
| alltime | all time | -2709.8% | at low | -7845.1% | +23.2% | -5829.5% | at low |
Immix Biopharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.04 M(-23.2%) | -$15.80 M(+6.4%) |
| Jun 2024 | - | -$5.26 M(+37.3%) | -$14.85 M(+13.3%) |
| Mar 2024 | - | -$3.83 M(+42.9%) | -$13.11 M(+15.3%) |
| Dec 2023 | -$11.37 M(+53.5%) | -$2.68 M(-13.3%) | -$11.37 M(-9.7%) |
| Sep 2023 | - | -$3.09 M(-12.2%) | -$12.60 M(+14.8%) |
| Jun 2023 | - | -$3.52 M(+68.0%) | -$10.97 M(+37.1%) |
| Mar 2023 | - | -$2.09 M(-46.4%) | -$8.01 M(+8.1%) |
| Dec 2022 | -$7.41 M | -$3.90 M(+166.9%) | -$7.41 M(+60.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.46 M(+167.3%) | -$4.62 M(+44.0%) |
| Jun 2022 | - | -$547.10 K(-63.4%) | -$3.21 M(+13.8%) |
| Mar 2022 | - | -$1.49 M(+34.2%) | -$2.82 M(+77.3%) |
| Dec 2021 | -$1.59 M(+292.7%) | -$1.11 M(+2093.1%) | -$1.59 M(+234.4%) |
| Sep 2021 | - | -$50.80 K(-67.8%) | -$475.20 K(+12.0%) |
| Jun 2021 | - | -$158.00 K(-40.7%) | -$424.40 K(+59.3%) |
| Mar 2021 | - | -$266.40 K | -$266.40 K |
| Dec 2020 | -$404.70 K(-48.8%) | - | - |
| Dec 2019 | -$790.00 K | - | - |
FAQ
- What is Immix Biopharma annual cash flow from operations?
- What is the all time high annual CFO for Immix Biopharma?
- What is Immix Biopharma annual CFO year-on-year change?
- What is Immix Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Immix Biopharma?
- What is Immix Biopharma quarterly CFO year-on-year change?
- What is Immix Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for Immix Biopharma?
- What is Immix Biopharma TTM CFO year-on-year change?
What is Immix Biopharma annual cash flow from operations?
The current annual CFO of IMMX is -$11.37 M
What is the all time high annual CFO for Immix Biopharma?
Immix Biopharma all-time high annual cash flow from operations is -$404.70 K
What is Immix Biopharma annual CFO year-on-year change?
Over the past year, IMMX annual cash flow from operations has changed by -$3.96 M (-53.50%)
What is Immix Biopharma quarterly cash flow from operations?
The current quarterly CFO of IMMX is -$4.04 M
What is the all time high quarterly CFO for Immix Biopharma?
Immix Biopharma all-time high quarterly cash flow from operations is -$50.80 K
What is Immix Biopharma quarterly CFO year-on-year change?
Over the past year, IMMX quarterly cash flow from operations has changed by -$949.40 K (-30.76%)
What is Immix Biopharma TTM cash flow from operations?
The current TTM CFO of IMMX is -$15.80 M
What is the all time high TTM CFO for Immix Biopharma?
Immix Biopharma all-time high TTM cash flow from operations is -$266.40 K
What is Immix Biopharma TTM CFO year-on-year change?
Over the past year, IMMX TTM cash flow from operations has changed by -$3.20 M (-25.39%)